Design Therapeutics to participate in 2026 Cantor Fitzgerald healthcare conference chat
Design Therapeutics said management will participate in a fireside chat during the 2026 Cantor Fitzgerald Global Healthcare Conference.
CARLSBAD, Calif., Sept.
02, 2026 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc.
NASDAQ:DSGN, a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a fireside chat during the 2026 Cantor Fitzgerald G…